| Grant Michael Milam, DPT | |
|
55 Unitypoint Way Ste 70, Marshalltown, IA 50158-4749 | |
| (641) 754-6120 | |
| Not Available |
| Full Name | Grant Michael Milam |
|---|---|
| Gender | Male |
| Speciality | Physical Medicine & Rehabilitation |
| Location | 55 Unitypoint Way Ste 70, Marshalltown, Iowa |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1881390771 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208100000X | Physical Medicine & Rehabilitation | 117217 (Iowa) | Primary |
| Entity Name | Central Iowa Physio Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1821488800 PECOS PAC ID: 2062732118 Enrollment ID: O20150930000716 |
News Archive
Building on the strengths of two institutions separated by nearly 9,000 miles over two continents - both renowned in their work in the fight against cancer - the United States Agency for International Development has awarded a $500,000 grant to Fred Hutchinson Cancer Research Center to aid in the construction of the first American cancer clinic and medical-training facility in Africa.
In a feature analysis, Devex examines the history of PEPFAR, the program's sustainability, its use of public-private partnerships, and the potential impact of the closure earlier this month of the Global Health Initiative (GHI) office.
BioNTech AG and Ganymed Pharmaceuticals AG, two premier German biotechology companies, announced today the joint- opening of a new approx. 10,000 square-meters (108,000 square-feet) headquarters and research facility.
With the number of deaths caused by high blood pressure on the rise in the United States, the American Medical Association is joining the American Heart Association to increase public awareness of this "silent killer."
A variety of smoking cessation treatments are currently available for the more than 18 million adult Americans try to quit smoking each year, but success rates vary widely. Despite the importance of quitting smoking, more personalized approaches to smoking cessation treatment are needed to help smokers pick the right method that will work best for them. A major new personalized medicine clinical trial, led by addiction researchers at the University of Pennsylvania, will study how a smokers' genetic make-up influences their quitting success.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Grant Michael Milam, DPT 55 Unitypoint Way Ste 70, Marshalltown, IA 50158-4749 Ph: () - | Grant Michael Milam, DPT 55 Unitypoint Way Ste 70, Marshalltown, IA 50158-4749 Ph: (641) 754-6120 |
News Archive
Building on the strengths of two institutions separated by nearly 9,000 miles over two continents - both renowned in their work in the fight against cancer - the United States Agency for International Development has awarded a $500,000 grant to Fred Hutchinson Cancer Research Center to aid in the construction of the first American cancer clinic and medical-training facility in Africa.
In a feature analysis, Devex examines the history of PEPFAR, the program's sustainability, its use of public-private partnerships, and the potential impact of the closure earlier this month of the Global Health Initiative (GHI) office.
BioNTech AG and Ganymed Pharmaceuticals AG, two premier German biotechology companies, announced today the joint- opening of a new approx. 10,000 square-meters (108,000 square-feet) headquarters and research facility.
With the number of deaths caused by high blood pressure on the rise in the United States, the American Medical Association is joining the American Heart Association to increase public awareness of this "silent killer."
A variety of smoking cessation treatments are currently available for the more than 18 million adult Americans try to quit smoking each year, but success rates vary widely. Despite the importance of quitting smoking, more personalized approaches to smoking cessation treatment are needed to help smokers pick the right method that will work best for them. A major new personalized medicine clinical trial, led by addiction researchers at the University of Pennsylvania, will study how a smokers' genetic make-up influences their quitting success.
› Verified 5 days ago